Methylcobalamin + PregabalinThird Party Manufacturing in India

Methylcobalamin and Pregabalin is a rationally designed fixed-dose combination for the management of neuropathic pain, combining a neurotropic vitamin with a structural anticonvulsant through complementary mechanisms. Methylcobalamin, the active coenzyme form of vitamin B12, directly participates in the synthesis of myelin basic protein and promotes regeneration of the Schwann cell-axon unit. It enhances nerve conduction velocity by supporting the methylation cycle required for myelin phospholipid synthesis, and promotes axonal transport of neurotrophic factors. By donating methyl groups in the methionine synthase reaction, methylcobalamin supports the production of S-adenosylmethionine, which is essential for neuronal membrane stability and neurotransmitter synthesis. Pregabalin, a structural analogue of gamma-aminobutyric acid, binds with high affinity to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. This binding reduces the influx of calcium ions into hyper-excited neurons, thereby decreasing the release of excitatory neurotransmitters including glutamate, norepinephrine, and substance P from presynaptic terminals. By reducing neurotransmitter release, pregabalin dampens the hyperexcitability of spinal cord dorsal horn neurons that characterizes neuropathic pain states. Together, methylcobalamin supports structural nerve repair while pregabalin provides symptomatic pain relief through central neuromodulation.

Therapeutic Uses

Methylcobalamin + Pregabalin is prescribed for the treatment of neuropathic pain conditions:

• Diabetic Peripheral Neuropathy: This combination is widely prescribed for the burning, tingling, and numbness associated with diabetic neuropathy. Methylcobalamin supports nerve regeneration while pregabalin provides rapid pain relief.
• Postherpetic Neuralgia: Effective for persistent nerve pain following herpes zoster infection, reducing both the intensity and frequency of pain episodes.
• Trigeminal Neuralgia: Used as part of combination therapy for this severe facial pain condition.
• Sciatica and Lumbar Radiculopathy: Provides relief from nerve root compression-related pain and paresthesias.
• Cervical and Lumbar Spondylosis: Addresses neuropathic symptoms arising from degenerative spinal conditions.
• Chemotherapy-Induced Peripheral Neuropathy: Increasingly used to manage the often dose-limiting neuropathic side effects of platinum-based and taxane chemotherapies.

Why Manufacturers Choose Methylcobalamin + Pregabalin

This combination addresses the growing epidemic of diabetic neuropathy in India, where over 77 million people have diabetes and approximately 50% develop neuropathy. Pregabalin is the first-line pharmacotherapy for neuropathic pain as per international guidelines, and methylcobalamin is the standard neurotrophic supplement in India. The fixed-dose combination improves compliance by reducing pill burden. The Indian pharmaceutical industry has established supply chains for both molecules, with multiple API sources and proven formulation expertise. The product commands strong demand from PCD franchise networks, hospital supplies, and export markets in Africa, the Middle East, and Southeast Asia where diabetic neuropathy prevalence is also rising. This makes Methylcobalamin + Pregabalin one of the most commercially viable neurological formulation for third party manufacturing in India.